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Abstract
Background: Empirical evidence supporting the distinction between suicide attempt (SA) and non-suicidal self-
harm (NSSH) is lacking. Although NSSH is a risk factor for SA, we do not currently know whether these behaviours
lie on a continuum of severity, or whether they are discrete outcomes with different aetiologies. We conducted this
exploratory genetic epidemiology study to investigate this issue further.
Methods: We explored the extent of genetic overlap between NSSH and SA in a large, richly-phenotyped cohort
(the Avon Longitudinal Study of Parents and Children; N = 4959), utilising individual-level genetic and phenotypic
data to conduct analyses of genome-wide complex traits and polygenic risk scores (PRS).
Results: The single nucleotide polymorphism heritability of NSSH was estimated to be 13% (SE 0.07) and that of SA
to be 0% (SE 0.07). Of the traits investigated, NSSH was most strongly correlated with higher IQ (rG = 0.31, SE =
0.22), there was little evidence of high genetic correlation between NSSH and SA (rG = − 0.1, SE = 0.54), likely due to
the low heritability estimate for SA. The PRS for depression differentiated between those with NSSH and SA in
multinomial regression. The optimal PRS prediction model for SA (Nagelkerke R2 0.022, p < 0.001) included ADHD,
depression, income, anorexia and neuroticism and explained more variance than the optimal prediction model for
NSSH (Nagelkerke R2 0.010, p < 0.001) which included ADHD, alcohol consumption, autism spectrum conditions,
depression, IQ, neuroticism and suicide attempt.
Conclusions: Our findings suggest that SA does not have a large genetic component, and that although NSSH and
SA are not discrete outcomes there appears to be little genetic overlap between the two. The relatively small
sample size and resulting low heritability estimate for SA was a limitation of the study. Combined with low
heritability estimates, this implies that family or population structures in SA GWASs may contribute to signals
detected.
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Background
Self-harm is a major public health concern. It is the
strongest predictor of completed suicide and is par-
ticularly common among young people; a group in
which rates of serious self-harm appear to be rising
[1]. Genome-wide association studies (GWASs) have
advanced our understanding of the genetic architec-
ture of many complex traits. Yet, in comparison to
other psychiatric traits [2–5], the genetic epidemi-
ology of suicide and self-harm remains poorly under-
stood. Whilst emerging evidence from twin studies
estimate heritability of 17–55% for suicide and suicide
attempts (SA) [6, 7], single nucleotide polymorphism
(SNP)-based heritability estimates of SA are much
smaller at 2–6% [8, 9].
Understanding the genetic basis of suicide is compli-
cated by the broad spectrum of behaviours that fall
under “suicidal behaviour”, which include self-harm with
varying levels of suicidal intent as well as death by sui-
cide. Within this broad definition there is a lack of con-
sensus as to whether self-harm without suicidal intent
(referred to as ‘non suicidal self-harm’ (NSSH)) and SA
lie on a continuum of increasingly severe and lethal be-
haviour, or whether they should be considered discrete
[10, 11]. This debate has been fuelled by the addition of
both ‘non-suicidal self-injury’ and ‘suicidal behaviour
disorder’ in the DSM-5 as conditions for further study
[10, 12]. The existing observational evidence suggests
that NSSH and SA share some risk factors, whilst others
may be unique to one type of behaviour [13, 14]. How-
ever, disentangling the aetiology of these behaviours
using observational data is challenging due to unmeas-
ured and residual confounding [15]. Utilising genetic
data to explore relationships between risk factors and
suicidal behaviour reduces the potential for confounding
and allows for a more nuanced exploration of traits that
may confer liability to NSSH and/or SA.
Polygenic risk scores (PRS) utilise information from
thousands of genetic variants to characterise a given
individual’s genetic risk for a trait of interest [16, 17]. A
recent study exploring risk for self-harm using the UK
BioBank, a large well-characterised sample of middle-
aged adults, found evidence of association between self-
harm and PRSs for depression, schizophrenia, ADHD,
bipolar disorder, alcohol use, and cannabis use, but no
evidence for differential prediction of NSSH and SA
[18]. A further study also utilising UK BioBank found
positive genetic correlations of SA with neuroticism,
schizophrenia and major depressive disorder (MDD) [8].
However, UK Biobank is socially-advantaged [19], and
reports of lifetime self-harm and suicide attempt are very
low compared with longitudinal cohorts [8, 13]. As such,
further studies are needed to investigate whether these
findings are generalisable to other samples.
This study uses data from the Avon Longitudinal
Study of Parents and Children (ALSPAC) birth cohort to
explore the genetic architecture and overlap of NSSH
and SA, utilising individual-level genetic and phenotypic
data to conduct genome-wide complex traits analysis
and PRS prediction. Specifically, we aimed to:
1) Explore the SNP-based heritability of NSSH and
SA, as well as other related psychological traits and
sociodemographic risk factors previously associated
with NSSH or SA.
2) Assess the genetic correlation between these related
exposures, NSSH and SA.
3) Explore whether PRS for psychological and




ALSPAC recruited pregnant women resident in Avon,
UK with expected delivery dates between 1st April 1991
and 31st December 1992. The initial number of preg-
nancies enrolled was 14,541. Of these, 13,988 children
were alive at 1 year of age [20–22], and genotype data
were available for 8237. Data were collected via regular
questionnaires and research clinics [23, 24]. Details of all
data is available through a fully searchable data diction-
ary and variable search tool (http://www.bristol.ac.uk/
alspac/researchers/our-data/). Ethical approval for the
study was obtained from the ALSPAC Ethics and Law
Committee and the Local Research Ethics Committees,
and consent for biological samples has been collected in
accordance with the Human Tissue Act (2004).
ALSPAC children were genotyped using the Illumina
HumanHap550 quad chip genotyping platforms by
23andMe subcontracting the Wellcome Trust Sanger
Institute, Cambridge, UK and the Laboratory Corpor-
ation of America, Burlington, NC, US. Following quality
control assessment and imputation (see Supplementary
Methods), genetic data was available for 8237 ALSPAC
individuals.
Non-suicidal self-harm and suicide attempt
ALSPAC participants reported at ages 16, 21, and 24
years whether they had “ever hurt [them]self on purpose
in any way (e.g. by taking an overdose of pills, or by cut-
ting [themselves])”. They were then asked if they “have
ever seriously wanted to kill themselves on any occasion
where they have hurt themselves” or whether the “last
time they hurt themselves it was because they wanted to
die”. Four thousand nine hundred and fifty-nine individ-
uals had data from at least one time point. Responses
were used to categorise participants into three groups:
NSSH (17.0%, yes to self-harm, never reported intent to
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die), SA (9.5%, yes to self-harm, reported intent to die
on at least one occasion), or no self-harm (73.5%). Three
separate outcomes were utilised in the analyses: NSSH
vs all others, SA vs all others, and a three-level outcome
(no self-harm NSSH and SA). In addition, a further
measure of SA was derived using an additional wave of
ALSPAC data at age 26 years to match the phenotype
used within a recent SA GWAS [9] .
Genome-wide association study of non-suicidal self-harm
and suicide attempt
We conducted a GWAS of NSSH and SA in ALSPAC
using snptest, adjusting for age, sex and population sub-
structure by including the first ten principle compo-
nents. Results were filtered based on minor allele
frequency of > 0.01 and an imputation quality (info)
score of > 0.3.
Estimating SNP heritability
Genome-wide complex traits analysis (GCTA) [25] was
implemented to investigate SNP heritability (h2SNP) or
the proportion of the variance of each phenotype ex-
plained by all observed SNPs for NSSH, SA and the 17
exposure phenotypes. A genetic relatedness matrix was
calculated from Hapmap3 SNPs in unrelated child par-
ticipants of ALSPAC. The heritability of each trait was
estimated using restricted maximum likelihood analysis
(REML), adjusting for the first 10 principal components
and sex as covariates to mitigate confounding from
population stratification. A complementary method of
assessing SNP heritability is linkage disequilibrium score
regression (LDSC) [26], which we also applied to GWAS
results of NSSH and SA in ALSPAC.
Genetic correlations
We aimed to assess genetic correlations (rG) between
NSSH, SA and related phenotypes using bivariate
REML [27].
Polygenic risk score analyses
PRS were derived in ALSPAC for phenotypes shown to
relate to NSSH/SA utilising external GWAS summary
data, none of which contained ALSPAC participants.
These phenotypes included psychiatric disorders, per-
sonality traits, sociodemographic and lifestyle character-
istics (Table 1). Permission to use results from the MDD
and personality GWASs [2, 32] was acquired from
23andMe.
We used plink to calculate PRS as the sum of the
number of risk alleles a participant has (those with p-
values below a threshold), weighted by their effect
size [16]. PRS were created meeting a range of
thresholds (5 × 10− 8, 1 × 10− 7, 1 × 10− 6, 1 × 10− 5, 1 ×
10− 4, 0.001, 0.01, 0.05, 0.1, 0.2, 0.3, 0.4, 0.5) and
standardised (mean of 0 and standard deviation of 1)
prior to analyses. In order to determine the most ap-
propriate threshold for each PRS, the associations be-
tween scores at each p-value threshold and ALSPAC
phenotypes that matched as closely as possible to
GWAS traits of interest (Table 1) were evaluated in
regression models. The model with the largest R2 or
Nagelkerke R2 for each phenotype was considered op-
timal, and the PRS at this threshold selected for the
analyses.
A series of multinomial logistic regressions were first
used to examine the association between each exposure
PRS and a three-level outcome of no self-harm, NSSH
and SA. The mean and variance of the self-harm out-
come measure were similar (0.36 and 0.42 respectively),
combined with results of goodness of fit tests this indi-
cated that a Poisson regression model was suitable, with
overdispersion not being a significant issue (p > 0.05).
We then applied k-fold cross-validation lasso regression
to ascertain the combination of polygenic scores that
best predicted i) NSSH (vs all others) and ii) SA (vs all
others). Ten folds were specified: for each iteration 90%
of the data were used as the training sample and 10% as
the prediction sample. Given the relatively small number
of SA cases, we repeated the predication model for SA
in post-hoc analyses using varying numbers of folds (k =
2–6). Results were consistent with the 10-fold model.
Optimal predictive models for NSSH and SA were thus
identified. For SA, we assessed whether the optimal pre-
diction model accounted for more variance than using
the PRS for SA derived from the external GWAS. No ex-
ternal PRS was available for NSSH for comparison. Ana-
lyses were conducted in Stata v15.
Results
SNP heritability
Sample sizes with both phenotypic and genetic data
ranged from 1909 (cannabis use) to 7794 (Autistic
Spectrum Conditions (ASC)). NSSH was estimated to
have a h2SNP of 0.132 (SE 0.07): 13.2% of the variance
in NSSH was explained by common genetic variants
(Table 2). In contrast, SA by age 24 years had negligible
SNP heritability, and a large standard error relative to
the estimate (h2SNP 0.000, SE 0.07) indicating greater
uncertainty in the estimation of heritability for SA.
When extending the SA phenotype to age 26 years, we
found a h2SNP of 0.064 (SE 0.07). Heritability estimates
from LDSC were consistent but with lower precision
(Table 2).
Genetic correlations between NSSH, SA and related
phenotypes
As SNP heritability for SA was negligible, genetic corre-
lations were only estimated between NSSH and related
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Table 1 Related phenotype definitions in ALSPAC and other genome-wide association study data















561,190 Major depression- diagnostic
interview/medical records/self-
reported diagnosis or treatment for
clinical depression
SMFQ > = 11, DAWBA depression at
7, 13 or 15, 17 years, self-report of









64,643 cases diagnosed Self-reported “ever diagnosed with
schizophrenia” asked at age 22







20,183 cases diagnosed DAWBA diagnosis at 7, 10, 13 or 15 3.31%
Autism Spectrum
Disorders (ASC)




27,969 registry-based cases Mother report of Autism Spectrum
Disorder diagnosis at age 7, in 2.5th
percentile on autism traits at 9 years
old, report of additional education
or work support for autism or
Asperger’s
2.46%




6024 44,240 Clinically-registered suicide attempts
in psychiatric cases
suicide attempt ever by age 26-
derived as for suicide attempt
above plus self-reported “attempted
suicide in past 12 months” at age 26










7016 14,745 Standardised assessment instruments
were used to generate DSM-based
Anxiety disorder diagnoses, with
some exceptions
Any anxiety disorder by DAWBA,









2387 48,985 Clinical records of ICD-10 codes for
cannabis dependence







Self-reported average intake of
alcohol consumption in units per
week.
Average number of units per week
based on frequency and number of
drinks self-reported age 22 and 24
mean 2.83, SD
3.19
Openness Lo (2016) [32] 76,
551
Big-5, NEO Five-factor inventory and
other validated personality measures
Big-5 questionnaire age 13 mean 35.8, SD
5.65
Conscientiousness Lo (2016) [32] 59,
225
Big-5, NEO Five-factor inventory and
other validated personality measures
Big-5 questionnaire age 13 mean 31.9, SD
5.82







Big-5, NEO Five-factor inventory and
other validated personality measures
Big-5 questionnaire age 13 mean 35.3, SD
6.87
Agreeableness Lo (2016) [32] 76,
551
Big-5, NEO Five-factor inventory and
other validated personality measures






Big-5, NEO Five-factor inventory and
other validated personality measures
Big-5 questionnaire age 13 mean 28.4, SD
6.58






55,525 Case definitions established a lifetime
diagnosis of anorexia nervosa via
hospital or register records, structured
clinical interviews, or online
questionnaires based on standardised
criteria. In the UK Biobank, cases self-
reported a diagnosis of anorexia
nervosa
age 14, 16, 18, 24 range of
questions regarding BMI, fasting,






Different measures of intelligence
were assessed in each cohort but
were all operationalized to index a
common latent g factor underlying
multiple dimensions of cognitive
functioning








Binary education variable indexing
whether or not each participant had
self-reported attaining a college or
university-level degree.
Binary- whether report graduating
from University between age 21
and 24
47%
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phenotypes (Fig. 1, Supplementary Table 1). No expos-
ure trait had robust evidence of correlation with NSSH:
all rG estimate 95% confidence intervals (CIs) crossed
the null. Of all the related phenotypes, IQ had the stron-
gest evidence for correlation with NSSH (rG = 0.31 SE =
0.22 p = 0.08), and NSSH showed little evidence of cor-
relation with the SA measure at up to age 26 (rG = −
0.10 SE 0.54 p = 0.43).
Differential association and prediction of NSSH and SA
using polygenic risk scores
In the multinomial regression models (Table 3 and
Supplementary Figure 1), the standardised PRS for
ADHD, ASC, depression, neuroticism, agreeableness and
suicide attempt were associated with both NSSH and
SA. There was also tentative evidence for an association
between the PRS for schizophrenia and both outcomes.
Table 1 Related phenotype definitions in ALSPAC and other genome-wide association study data (Continued)











Hill (2016) [38] 112,
151
Self-reported using a 5 point scale
corresponding to the total household
income before tax, 1 being less than
£18,000, 2 being £18,000 - £29,999, 3
being £30,000 - £51,999, 4 being £52,
000 – £100,000, and 5 being greater
than £100,000
Average take-home income at age
22 and/or 23, split into 5 bands
mean 2.91, SD
1.00
GPC Genetics of Personality Consortium, PRS polygenic risk score, GWAS genome-wide association study, ALSPAC Avon Longitudinal Study of Parents
and Children
Table 2 Estimated SNP heritability of psychiatric traits, personality and sociodemographic factors in ALSPAC using restricted
maximum likelihood analysis and linkage disequilibrium score regression
Trait n % cases h2SNP SE Log likelihood
Estimates from REML
Non-suicidal self-harm (main outcome) 4506 17.31 0.13 0.07 2174
Suicide attempt (main outcome) 4506 9.25 0.00 0.07 3345
ADHD 6440 3.14 0.01 0.05 8050
Alcohol consumption 3487 0.18 0.09 − 5760
Anorexia 5624 1.03 0.00 0.06 10,064
Anxiety 6644 15.12 0.04 0.05 3548
ASC 7794 2.56 0.00 0.04 10,434
Cannabis problematic use 1909 1.78 0.00 0.16 2891
Conscientiousness 4121 0.15 0.08 − 9272
Depression 6742 31.50 0.01 0.05 1940
Education 4007 49.45 0.38 0.08 784
Extraversion 4311 0.10 0.08 −10,407
Income 2929 0.00 0.11 − 1397
IQ 5672 0.37 0.06 −17,900
Neuroticism 4184 0.03 0.08 − 9818
Agreeableness 4239 0.14 0.08 − 8802
Schizophrenia 2744 < 0.50% 0.14 0.12 9446
Openness 4223 0.23 0.08 − 9360
Suicide attempt (by age 26) 4739 10.49 0.06 0.07 3249
Estimates from LDSC
NSSH 4518 17.31 0.008 0.096
SA (age 24) 4518 9.25 −0.109 0.098
SA (age 26) 4518 10.49 − 0.109 0.098
REML restricted maximum likelihood analysis, LDSC linkage disequilibrium score regression, h2SNP SNP-based heritability, SE standard error, ADHD attention deficit/
hyperactivity disorder, ASC autism spectrum conditions, NSSH non-suicidal self-harm, SA suicide attempt
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Depression was the only predictor that was differentially
associated with NSSH and SA whereby associations were
markedly stronger for SA than NSSH (NSSH RR 1.17,
95% CI 1.08, 1.27; SA RR 1.47, 95% CI 1.32, 1.63). For
some PRS associations were found for one behaviour
only (although CIs overlapped). For example, PRS for
IQ, alcohol consumption and education were associated
with NSSH but not SA, whereas PRS for anorexia and
lower income were associated with SA but not NSSH.
We found no strong evidence of associations between
PRS for anxiety, cannabis use, conscientiousness, extra-
version, or openness with either outcome.
The optimal prediction model for SA included PRSs
for ADHD, depression, income, anorexia and neuroti-
cism. The model had a Nagelkerke R2 of 0.0222 (p <






















































































Fig. 1 Bivariate restricted-maximum likelihood analysis showing genetic correlation between non-suicidal self-harm and related phenotypes.
Notes: rG genetic correlation; error bars represent 95% confidence interval of rG estimate. ADHD attention deficit/hyperactivity disorder; ASC
Autism spectrum conditions. Confidence intervals for income and cannabis use were extremely wide and so are not shown
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measured PRSs. This was higher than Nagelkerke R2
calculated from the model including the PRS for SA
alone (Nagelkerke R2 = 0.12%). The optimal prediction
model for NSSH had a Nagelkerke R2 of 0.0104 (p <
0.001). This model included ADHD, alcohol con-
sumption, ASC, depression, IQ, neuroticism and sui-
cide attempt (Supplementary Table 2). Betas were
much larger for SA than NSSH for both ADHD and
depression. Supplementary Table 3 shows the model
fit statistics for optimal models. The findings from
the PRS multinomial and prediction models are sum-
marised in Fig. 2.
Discussion
We explored the genetic architecture and overlap be-
tween non-suicidal self-harm and suicide attempt using
detailed phenotypic and genotype data from the ALSP
AC cohort. Our findings suggest that the variance cap-
tured by SNPs is small, and there was a greater propor-
tion of common genetic variation explained for NSSH
than SA. These heritability estimates were lower than
for personality and sociodemographic traits such as alco-
hol consumption, but similar to other psychiatric pheno-
types in our sample. Twin studies have estimated the
heritability of suicidal behaviours to be between 17 and
48% [7]. The SNP-based heritability estimate for SA was
in line with other studies [8, 9], and although our esti-
mate increased to 6% when including an extra 2 years of
data, standard errors were large. There are several po-
tential explanations for this: the sample with SA at 26
years includes an additional 131 individuals with a his-
tory of SA compared with age 24 years, which may have
provided additional statistical power to calculate herit-
ability. It may also be that there are differences in the
aetiology of SA between adolescence and young adult-
hood. Future studies should examine whether there is
evidence to support this.
The small genetic correlations indicated little overlap
between the genetic architectures of NSSH and related
phenotypes, supporting evidence that NSSH does not
solely occur in the context of psychiatric disorder [39].
Although we were unable to explore genetic correlations
for related phenotypes with SA in ALSPAC due to its
negligible heritability, we found little evidence of
Fig. 2 Summary of findings
Table 3 Multinomial Poisson logistic regression results (n =
4959) showing association between polygenic risk score for 17
related phenotypes with non-suicidal self-harm and suicide
attempt
Non-suicidal self-harm Suicide attempt
Exposure RR 95% CI RR 95% CI
ADHD 1.10 1.02, 1.19 1.21 1.09, 1.34
Alcohol 1.07 0.98, 1.16 0.99 0.89, 1.10
Anorexia 1.01 0.93, 1.09 1.12 1.01, 1.23
Anxiety 0.98 0.90, 1.05 0.96 0.87, 1.06
ASC 1.09 1.01, 1.18 1.09 0.98, 1.20
Cannabis 1.03 0.95, 1.11 0.99 0.89, 1.09
Conscientiousness 1.02 0.94, 1.10 1.00 0.90, 1.11
Depression 1.17 1.08, 1.27 1.47 1.32, 1.63
Education 1.04 0.96, 1.12 0.97 0.88, 1.07
Extraversion 0.98 0.91, 1.06 0.97 0.88, 1.08
Income 1.01 0.93, 1.09 0.90 0.81, 0.99
IQ 1.14 1.06, 1.24 1.02 0.92, 1.13
Neuroticism 1.16 1.08, 1.26 1.27 1.14, 1.40
Agreeableness 0.94 0.87, 1.02 0.93 0.84, 1.03
Schizophrenia 1.05 0.97, 1.14 1.06 0.96, 1.17
Openness 1.01 0.93, 1.09 1.02 0.92, 1.13
Suicide attempt 1.07 0.99, 1.15 1.10 0.99, 1.21
Reference category: no self-harm. Polygenic scores standardised to have mean
0 and standard deviation 1 so the RR represents the change in risk of the
outcome per 1 standard deviation increase in polygenic risk score
ADHD attention deficit/hyperactivity disorder, ASC autism spectrum conditions
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correlation between NSSH and SA measured up to age
26 (matching the external GWAS), suggesting they share
little genetic overlap. However, our findings must be
considered alongside acknowledgement of our relatively
small sample size and large standard errors around our
rG estimates; sampling error may outweigh any signal.
This particularly applies to schizophrenia, problematic
cannabis use, and anorexia, where the prevalence of each
was very low in ALSPAC. This would affect bREML
analyses but not PRS as those scores were derived using
external GWAS data.
Our estimates of shared heritability between our
related phenotypes and NSSH are smaller than those of
a similar study that calculated genetic overlap between
psychiatric traits, (although not NSSH or SA) that re-
ported correlations between phenotypes of up to 50%
[40]; further research with larger sample sizes is needed
in order to confirm whether NSSH has relatively weaker
genetic correlations with psychiatric disorders than other
traits. If our finding is replicated, this implies that gen-
etic risk for NSSH may be independent of genetic risk
for other psychopathologies.
Prior analysis of observational data in ALSPAC found
IQ and maternal education were differentially associated
(opposite directions) with NSSH and SA [13]. Depres-
sion, anxiety and substance dependence were found to
have stronger associations with SA than NSSH (although
were associated with both) [13]. In the current study, we
found an association between the PGS for IQ and NSSH
but not for SA (although the CIs overlapped) and IQ
showed the strongest evidence of a genetic correlation
with NSSH. Low IQ has been associated with suicide
and SA in several prior studies [41–43] but the associ-
ation with NSSH has been relatively unexplored.
Our phenotypes of self-harm and suicide attempt were
restricted to early onset suicidal behaviour, as the cohort
was age 26 at the final measurement point. The impacts of
this may mean that we underestimated differences be-
tween those with NSSH and SA. Self-harm is most preva-
lent in younger age groups and frequently has an onset
before the age of 17 [44, 45], however suicide attempt may
have a much later age of onset; a study in 2012 found that
over 30% of suicide attempts and other suicidal behaviour
were initiated over the age of 30 years [46]; another study
found a median age of onset of suicidal behaviour of 55
years, and different factors were associated with early and
late-onset suicidality. For example, earlier-onset suicidal
behaviour has been associated with negative life events,
maladaptive personality traits, more difficulty regulating
behaviour and planning ahead, whereas later-onset suicide
attempt (after age 55) appears to be linked more closely to
proximal stressful life events [47]. Our findings therefore
cannot be generalised into older populations without fur-
ther investigation.
The findings from our multinomial regression provide
tentative evidence that some risk factors for NSSH and
SA are shared, whereas others may be specific, although
the standard errors of many of our estimates were very
large. Depression was the only shared risk factor that
was clearly more strongly associated with SA than
NSSH. This replicates previous observational findings [8,
14, 48–50]. However, other previously-reported observa-
tional associations were not replicated in our analysis.
For example, we did not find evidence for an association
between the PRS for anxiety and either outcome,
whereas some prior studies have found anxiety to be
more strongly related to SA than to NSSH [14, 48, 51].
In addition, neuroticism has been found to be more
strongly associated with SA in observational studies [52],
and with SA but not NSSH in a prior PRS study [18]
whereas we found it to be similarly associated with both
outcomes.
Strengths and limitations
ALSPAC is a population-based birth cohort that is
broadly representative of the general UK population. De-
tailed phenotypic information was available on a wide
range of exposures and data were collected prospectively
and often using validated measures (see Table 1). Preva-
lence estimates of NSSH were 17.0% and SA 9.5% in our
sample which is in line with other epidemiological stud-
ies [53]. It should be noted that these can be considered
“early onset” suicidal behaviour, given that age 26 years
was our latest measure of self-harm, and therefore our
findings may not generalise to apply to suicidal behav-
iour across the life course. Terminology and definitions
of self-harm are complex and vary across countries and
individual studies. In the UK, self-harm is commonly
used as an umbrella term to capture self-injurious acts
regardless of intent [54], and in this study we have de-
fined suicide attempt as being a history of self-harm with
self-reported intent to die in at least one self-harm
event.
The clinical reality is more complex, and those who
self-harm may vary in their intent between episodes as
well as over time, as such our approach may be reduc-
tionist and prone to potential reporting difficulties. In
addition, different methods of self-harm (which them-
selves are patterned by gender) are differentially associ-
ated with suicidal intent. Completed suicide is associated
with previous suicidal intent for the majority of individ-
uals, but not all [54]. A more nuanced understanding of
self-harm and comprehensive assessment of the nature,
purpose and intent of self-harm is needed in future stud-
ies to overcome these limitations.
Our estimates of NSSH and SA are substantially
higher than those reported in UK BioBank (a large, con-
venience, socially-advantaged sample) [8, 19], and these
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sample and phenotypic differences may explain differ-
ences between our PRS findings and recent UK BioBank
studies [8, 18]. The largest current GWAS of SA outside
of UK BioBank [9] used psychiatric case records to iden-
tify a large number of cases which increased power,
however the sample is therefore not representative of
suicidal behaviour in the general population as many
had severe mental disorders. This may explain why we
did not find an association between the PRS for SA de-
rived from this previous GWAS and SA in ALSPAC.
Because the genetic basis of self-harm and suicidal
behaviour is still poorly understood, we cannot be sure if
we failed to find associations because there really is little
genetic basis to these traits, or because of a lack of statis-
tical power. Increased prediction power may become
achievable in the future as larger suicidal behaviour
GWASs become available through international collab-
oration such as that being led by the PGC [55]. The dif-
ferences between our heritability estimates for SA
between using data collected at age 24 and age 26 in
ALSPAC highlights the limitations of sample size on in-
ferring genetic heritability, and our analysis should be
considered exploratory in light of this.
In addition, we have defined NSSH and SA as binary
outcomes from self-reported data, however in actuality
these acts result from complex series of events and psy-
chological states, and our approach may be too reduc-
tionist [53]. There are limitations in the way that we
have measured and classified self-harm and suicide at-
tempt, as we do not capture the full spectrum of what is
considered to be suicidal behaviour [10, 11]. In this
study we have characterised NSSH and SA as discrete
behaviours, although the form in which the data were
collected required report of any self-harm are a pre-
requisite for participants to be asked about self-harm
with suicidal intent. We did not capture other forms of
suicidal behaviour in this data, such as suicidal thoughts
and our data do not capture the possibility of ‘suicidality’
without self-harm.
A further limitation of our study relates to the GWAS
summary statistics, from which we derived our PRS
scores. The sample sizes of GWASs affects their power
to detect associations with the exposures of interest, and
we note that we see the largest effect sizes correspond-
ing to the largest GWAS sample (depression), and null
effects for anxiety, which had the smallest GWAS sam-
ple (~ 21,000 participants). Caution is therefore required
when interpreting results from PRS. This highlights how
unreliable it may be to differentiate between the relative
aetiological overlaps between different traits using PRS,
because the results are largely driven by power. With in-
creasing sample sizes, these methods will become more
powerful and our ability to detect associations will im-
prove. Furthermore, although PRS are useful for
generating prediction models, effect sizes tend to be very
small as SNP-level variation explains only a small pro-
portion of the variation in the outcome.
Although genetic methods control for some problems of
confounding compared with using observational data, these
methods are still liable to bias through, for example, as-
sortative mating, dynastic effects and population stratifica-
tion [56, 57]. Our PRS prediction model performed better
for SA than NSSH, in spite of our finding little evidence of
SNP-based heritability of SA. This suggests that the
GWASs are potentially affected by residual confounding.
Although we controlled for the first 10 principal compo-
nents, this appears to be insufficient to fully capture re-
sidual confounding in this case. In practice this means our
PRS prediction models are over-estimating the variance ex-
plained. Finally, we included several sociodemographic
traits in our study, however it is important to note that
‘higher income’ or ‘having a degree’ are unlikely to be dir-
ectly related to specific genetic variants and these pathways
are therefore likely to be mediated by other characteristics
and personality traits, for example attention regulation or
cognitive abilities. Our alcohol exposure measure was based
on self-reported frequency and consumption of alcohol on
an average weekly basis, which may not tap-in to problem-
atic alcohol use or binge drinking patterns, and similar limi-
tations apply to other phenotypes such as cannabis use.
Implications
Our findings add to a growing body of science focussed on
understanding the genetic influences on self-harm and sui-
cidal behaviour. We found that NSSH and SA share some
genetic risk factors, including polygenic risk for SA derived
from a separate GWAS, but also that some factors (i.e. de-
pression) may be more strongly associated with SA than
NSSH. From prediction models, lower income and anorexia
appeared to uniquely predict SA, and higher IQ and educa-
tion uniquely predicted NSSH. Taken together, our findings
suggest that NSSH and SA are not simply a continuum of
increasingly severe suicidal behaviour, or discrete unrelated
outcomes: we found evidence that although NSSH and SA
are not categorically distinct outcomes there appears to be
little genetic overlap between the two.
If our findings are replicated, they can be used to inform
preventative interventions for young people at risk of NSSH
or SA. It would be of interest to explore whether our find-
ings reflect identifiable typologies, and whether individuals
who have several high-risk traits have common intermediary
pathways that put them at a higher risk of NSSH or SA. For
example, those with high IQ and high conscientiousness
may also have high levels of traits such as perfectionism,
which is associated with psychological distress. Poor coping
strategies for managing this distress may result in NSSH.
Some evidence also suggests that patterns of risk factors may
be different in the presence of specific disorders and this
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needs to be better understood; for example one study has
shown that in the presence of psychosis (a symptom of
schizophrenia), low IQ is not a risk factor for SA [58]. Fur-
ther genetic and observational epidemiological studies, con-
ducted in other large cohorts that have good coverage of
mental health data, are needed in order to replicate and ex-
tend our findings and to provide recommendations for prac-
titioners and policymakers who work in the field of self-
harm and suicide.
Conclusions
We explored the genetic architecture and overlap be-
tween non-suicidal self-harm and suicide attempt using
detailed phenotypic and genotype data from the ALSP
AC cohort. Our findings suggest that the variance cap-
tured by SNPs is small, and there was a greater propor-
tion of common genetic variation explained for NSSH
than SA. Our findings suggest that SA does not have a
large genetic component, and that although NSSH and
SA are not discrete outcomes there appears to be little
genetic overlap between the two.
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